PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm to present at Virtual Conference, Friday 27th March, page-43

  1. 826 Posts.
    lightbulb Created with Sketch. 328
    the annoying thing with treatments such as this is:
    1. Clearly it works .. the proof is in the results
    2. It will help a lot of people
    3. It is safe and is already being put into people in much greater doses than what PAR’s treatment program requires (emiron)
    4. It is non addictive and a naturally derived product

    why would this and treatments similar to this not be approved ASAP .. make them continue the phase 3 etc but at least get it out for people who need it. Instead regulation / red tape means a perfectly good and safe solution is another year away from hitting the market. Just does not make sense.
    i understand the public safety aspect but let’s face it if IPPS had long term detrimental effects even the phase 3 trial is not going to show that.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
24.0¢ 25.0¢ 23.0¢ $101.6K 424.7K

Buyers (Bids)

No. Vol. Price($)
12 144266 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 18540 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.